Psoriasis Clinical Trials in Houston

Showing 81-100 of 101 trials

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

NCT00688519

The purpose of the study is to demonstrate the safety and efficacy of U0267 in subjects with plaque-type psoriasis.

Stiefel, a GSK Company336 participantsStarted Mar 2008

San Diego, California, United States • Denver, Colorado, United States • Miami, Florida, United States +10 more locations

COMPLETEDPHASE2< 1 mile

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

NCT01537432

This study is designed to evaluate the proportion of patients achieving reversal of chronic plaque psoriasis at week 4 and 12 following multiple doses of secukinumab administered subcutaneously (sc) compared to placebo. Starting from week 13, all patients will receive multiple doses of secukinumab up to week 52 to study long term effects of secukinumab. Clinical endpoints including biomarker assessments, PASI, IGA and DLQI will be compared to better understand, why secukinumab may be effective in psoriasis patients.

Psoriasis, Plaque-type Psoriasis

Novartis Pharmaceuticals36 participantsStarted Jan 2012

Birmingham, Alabama, United States • Pasadena, California, United States • Indianapolis, Indiana, United States +9 more locations

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Psoriasis Trials in Other Cities

Tofacitinib Ointment For Chronic Plaque Psoriasis

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

A Study for Adults With Plaque Psoriasis

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

An Exploratory Genetic Study in Participants With Psoriasis

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

Other Conditions in Houston